Cross Country Healthcare, Inc.
NASDAQ:CCRNMedical - Care Facilities
+$0.01 today
- Market cap
- $428.06M
- Beta
- 0.45
- P/E (TTM)
- -4.2
- EPS (TTM)
- -$3.13
Volume 1.78M
Average 0.64M
CCRN Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Cross Country Healthcare, Inc.NASDAQ: CCRN
Gross Margin · Q1 FY2026 · quarter ended Mar 2026
Gross margin narrows to 18.2%
Gross margin was 18.2% in Q1 FY2026, down 1.8 pp from a year earlier. On a trailing-twelve-month basis it was 19.8%, down 0.5 pp year over year. Over 3 fiscal years it narrowed by 3.6 pp.
Context
- Gross margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 18.7%
- Year-over-year change
- -1.7pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 18.7% | -1.7pp |
| FY2024 | 2024-12-31 | 20.4% | -1.9pp |
| FY2023 | 2023-12-31 | 22.3% | +0.0pp |
| FY2022 | 2022-12-31 | 22.3% | -0.1pp |
| FY2021 | 2021-12-31 | 22.4% | — |
Gross Margin vs competitors
How CCRN compares with its peers on the latest reported figures
- CCRN's LTM Mar 2026 gross margin of 19.8% is the 6th highest of the 9 companies compared; the peer median is 52.5%.
- Its year-over-year change of -0.5 pp is the 5th highest of 9, against a peer median of -0.2 pp.
- Over three fiscal years its change of -3.6 pp compares with a peer median of -1.1 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 79.7% | -0.5 pp | -0.8 pp | |
| LTM Mar 2026 | 73.1% | +0.3 pp | -1.1 pp | |
| LTM Mar 2026 | 69.0% | +4.9 pp | +0.9 pp | |
MCTACharming Medical Limited Class A Ordinary Shares | FY2024 | 67.2% | +2.1 pp | — |
AUNAAuna S.A. | LTM Mar 2026 | 37.9% | -1.0 pp | +2.1 pp |
| LTM Mar 2026 | 19.8% | -0.5 pp | -3.6 pp | |
| LTM Mar 2026 | 14.8% | +0.1 pp | -5.4 pp | |
| LTM Mar 2026 | -2.7% | -2.4 pp | -7.8 pp | |
| LTM Mar 2026 | -29.9% | -132.2 pp | -96.5 pp | |
| Peer median (excluding CCRN) | 52.5% | -0.2 pp | -1.1 pp | |
Competitors are the stored peer set for CCRN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.68B | 2.8B | 2.02B | 1.34B | 1.05B |
| Cost of Revenue | 1.3B | 2.18B | 1.57B | 1.07B | 857.52M |
| Gross Profit | 375M | 624.46M | 450.41M | 274.25M | 196.78M |
| Gross Margin | 22.4% | 22.3% | 22.3% | 20.4% | 18.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 220.04M | 324.21M | 314.95M | 254.81M | 200.68M |
| Operating Expenses | 235.7M | 354.58M | 337.7M | 291.12M | 200.24M |
| Depreciation & Amortization | 9.45M | 12.58M | 18.35M | 17.5M | 16.79M |
| EBITDA | 154.56M | 280.06M | 129.34M | 16.77M | (64.5M) |
| EBITDA Margin | 9.2% | 10.0% | 6.4% | 1.2% | -6.1% |
| Operating Income | 139.3M | 269.88M | 112.71M | (16.87M) | (3.46M) |
| Operating Margin | 8.3% | 9.6% | 5.6% | -1.3% | -0.3% |
| Interest Income | 0 | 10K | 0 | 2.05M | 3.13M |
| Interest Expense | 6.87M | 14.39M | 8.09M | 2.19M | 2.22M |
| Other Income / Expenses | (6.1M) | (16.78M) | (9.82M) | 467K | (80.05M) |
| Income Before Tax | 133.21M | 253.1M | 102.89M | (16.4M) | (83.51M) |
| Pre-Tax Margin | 7.9% | 9.0% | 5.1% | -1.2% | -7.9% |
| Income Tax Expense | 1.21M | 67.12M | 30.26M | (1.84M) | 11.34M |
| Net Income | 132M | 185.98M | 72.63M | (14.56M) | (94.85M) |
| Net Margin | 7.9% | 6.6% | 3.6% | -1.1% | -9.0% |
| EPS (Basic) | 3.60 | 5.09 | 2.07 | (0.44) | (2.93) |
| EPS (Diluted) | 3.53 | 5.02 | 2.05 | (0.44) | (2.93) |
| Weighted Avg Shares | 36.69M | 37.01M | 35.16M | 33.38M | 32.41M |
| Weighted Avg Shares (Diluted) | 37.39M | 37.54M | 35.48M | 33.38M | 32.41M |
Cross Country Healthcare, Inc.
NASDAQ:CCRN
Intrinsic Alpha fair value
Locked
Current Price
$13.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.